Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and severe sepsis in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that are resistant to other agents.

Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with intra‑abdominal sepsis. Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection. Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant organisms. Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. Severe sepsis and septic shock: offers rapid bactericidal activity in critically ill patients.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: non‑specific skin eruption. - Injection site phlebitis: localized pain or redness. - Elevated liver enzymes: transient hepatic enzyme rise. - Headache: mild discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: risk increased in patients with CNS disorders or renal impairment. - Clostridioides difficile colitis: severe diarrhea due to overgrowth. - Renal toxicity: acute kidney injury in susceptible individuals. - Severe neutropenia: marked reduction in white blood cells. - Stevens‑Johnson syndrome: rare mucocutaneous blistering disorder.

Use meropenem with careful clinical monitoring.

Renal function: adjust dose in patients with impaired renal clearance. Seizure risk: monitor patients with a history of seizures or CNS disease. Allergy: avoid in individuals with known carbapenem hypersensitivity. Pregnancy: prescribe only when benefit outweighs potential risk to the fetus. Superinfection: watch for secondary fungal or bacterial infections. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Valproic acid: may reduce serum concentrations, decreasing seizure control. - Aminoglycosides: combined use can increase nephrotoxicity. - Loop diuretics: heightened risk of renal impairment.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Probenecid: can increase meropenem plasma levels, necessitating dose review. - Phenytoin: may alter seizure threshold, requiring clinical observation.